|
1
|
Libson S and Lippman M: A review of
clinical aspects of breast cancer. Int Rev Psychiatry. 26:4–15.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peto R, Davies C, Godwin J, Gray R, Pan
HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, et al: Early
Breast Cancer Trialists' Collaborative Group (EBCTCG): Comparisons
between different polychemotherapy regimens for early breast
cancer: Meta-analyses of long-term outcome among 100,000 women in
123 randomised trials. Lancet. 379:432–444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Videira M, Reis RL and Brito MA:
Deconstructing breast cancer cell biology and the mechanisms of
multidrug resistance. Biochim Biophys Acta. 1846:312–325.
2014.PubMed/NCBI
|
|
4
|
Kontos CK, Christodoulou MI and Scorilas
A: Apoptosis-related BCL2-family members: Key players in
chemotherapy. Anticancer Agents Med Chem. 14:353–374. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maines MD: The heme oxygenase system: A
regulator of second messenger gases. Annu Rev Pharmacol Toxicol.
37:517–554. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tenhunen R, Marver HS and Schmid R: The
enzymatic conversion of heme to bilirubin by microsomal heme
oxygenase. Proc Natl Acad Sci USA. 61:748–755. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alam J, Shibahara S and Smith A:
Transcriptional activation of the heme oxygenase gene by heme and
cadmium in mouse hepatoma cells. J Biol Chem. 264:6371–6375.
1989.PubMed/NCBI
|
|
8
|
Doi K, Akaike T, Fujii S, Tanaka S, Ikebe
N, Beppu T, Shibahara S, Ogawa M and Maeda H: Induction of haem
oxygenase-1 nitric oxide and ischaemia in experimental solid
tumours and implications for tumour growth. Br J Cancer.
80:1945–1954. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maines MD and Abrahamsson PA: Expression
of heme oxygenase-1 (HSP32) in human prostate: Normal,
hyperplastic, and tumor tissue distribution. Urology. 47:727–733.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Torisu-Itakura H, Furue M, Kuwano M and
Ono M: Co-expression of thymidine phosphorylase and heme
oxygenase-1 in macrophages in human malignant vertical growth
melanomas. Jpn J Cancer Res. 91:906–910. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hara E, Takahashi K, Tominaga T, Kumabe T,
Kayama T, Suzuki H, Fujita H, Yoshimoto T, Shirato K and Shibahara
S: Expression of heme oxygenase and inducible nitric oxide synthase
mRNA in human brain tumors. Biochem Biophys Res Commun.
224:153–158. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sunamura M, Duda DG, Ghattas MH, Lozonschi
L, Motoi F, Yamauchi J, Matsuno S, Shibahara S and Abraham NG: Heme
oxygenase-1 accelerates tumor angiogenesis of human pancreatic
cancer. Angiogenesis. 6:15–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cherrington JM, Strawn LM and Shawver LK:
New paradigms for the treatment of cancer: The role of
anti-angiogenesis agents. Adv Cancer Res. 79:1–38. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Was H, Cichon T, Smolarczyk R, Rudnicka D,
Stopa M, Chevalier C, Leger JJ, Lackowska B, Grochot A, Bojkowska
K, et al: Overexpression of heme oxygenase-1 in murine melanoma:
Increased proliferation and viability of tumor cells, decreased
survival of mice. Am J Pathol. 169:2181–2198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Berberat PO, Dambrauskas Z, Gulbinas A,
Giese T, Giese N, Künzli B, Autschbach F, Meuer S, Büchler MW and
Friess H: Inhibition of heme oxygenase-1 increases responsiveness
of pancreatic cancer cells to anticancer treatment. Clin Cancer
Res. 11:3790–3798. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noh SJ, Bae JS, Jamiyandorj U, Park HS,
Kwon KS, Jung SH, Youn HJ, Lee H, Park BH, Chung MJ, et al:
Expression of nerve growth factor and heme oxygenase-1 predict poor
survival of breast carcinoma patients. BMC Cancer. 13:5162013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Busserolles J, Megías J, Terencio MC and
Alcaraz MJ: Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via
activation of Akt pathway. Int J Biochem Cell Biol. 38:1510–1517.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen GG, Liu ZM, Vlantis AC, Tse GM, Leung
BC and van Hasselt CA: Heme oxygenase-1 protects against apoptosis
induced by tumor necrosis factor-alpha and cycloheximide in
papillary thyroid carcinoma cells. J Cell Biochem. 92:1246–1256.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bolisetty S, Traylor AM, Kim J, Joseph R,
Ricart K, Landar A and Agarwal A: Heme oxygenase-1 inhibits renal
tubular macroautophagy in acute kidney injury. J Am Soc Nephrol.
21:1702–1712. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Banerjee P, Basu A, Wegiel B, Otterbein
LE, Mizumura K, Gasser M, Waaga-Gasser AM, Choi AM and Pal S: Heme
oxygenase-1 promotes survival of renal cancer cells through
modulation of apoptosis- and autophagy-regulating molecules. J Biol
Chem. 287:32113–32123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: Apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen HM and Codogno P: Autophagic cell
death: Loch Ness monster or endangered species? Autophagy.
7:457–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mayerhofer M, Florian S, Krauth MT,
Aichberger KJ, Bilban M, Marculescu R, Printz D, Fritsch G, Wagner
O, Selzer E, et al: Identification of heme oxygenase-1 as a novel
BCR/ABL-dependent survival factor in chronic myeloid leukemia.
Cancer Res. 64:3148–3154. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nuhn P, Künzli BM, Hennig R, Mitkus T,
Ramanauskas T, Nobiling R, Meuer SC, Friess H and Berberat PO: Heme
oxygenase-1 and its metabolites affect pancreatic tumor growth in
vivo. Mol Cancer. 8:372009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Al-Owais MM, Scragg JL, Dallas ML, Boycott
HE, Warburton P, Chakrabarty A, Boyle JP and Peers C: Carbon
monoxide mediates the anti-apoptotic effects of heme oxygenase-1 in
medulloblastoma DAOY cells via K+ channel inhibition. J
Biol Chem. 287:24754–24764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jäger R, Herzer U, Schenkel J and Weiher
H: Overexpression of Bcl-2 inhibits alveolar cell apoptosis during
involution and accelerates c-myc-induced tumorigenesis of the
mammary gland in transgenic mice. Oncogene. 15:1787–1795. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Boise LH, González-García M, Postema CE,
Ding L, Lindsten T, Turka LA, Mao X, Nuñez G and Thompson CB:
Bcl-x, a bcl-2-related gene that functions as a dominant regulator
of apoptotic cell death. Cell. 74:597–608. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Samaddar JS, Gaddy VT, Duplantier J,
Thandavan SP, Shah M, Smith MJ, Browning D, Rawson J, Smith SB,
Barrett JT, et al: A role for macroautophagy in protection against
4-hydroxytamoxifen-induced cell death and the development of
antiestrogen resistance. Mol Cancer Ther. 7:2977–2987. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cufí S, Vazquez-Martin A,
Oliveras-Ferraros C, Corominas-Faja B, Cuyàs E, López-Bonet E,
Martin-Castillo B, Joven J and Menendez JA: The anti-malarial
chloroquine overcomes primary resistance and restores sensitivity
to trastuzumab in HER2-positive breast cancer. Sci Rep. 3:24692013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun WL, Chen J, Wang YP and Zheng H:
Autophagy protects breast cancer cells from epirubicin-induced
apoptosis and facilitates epirubicin-resistance development.
Autophagy. 7:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Veldhoen RA, Banman SL, Hemmerling DR,
Odsen R, Simmen T, Simmonds AJ, Underhill DA and Goping IS: The
chemotherapeutic agent paclitaxel inhibits autophagy through two
distinct mechanisms that regulate apoptosis. Oncogene. 32:736–746.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Denton D, Nicolson S and Kumar S: Cell
death by autophagy: Facts and apparent artefacts. Cell Death
Differ. 19:87–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Scarlatti F, Maffei R, Beau I, Codogno P
and Ghidoni R: Role of non-canonical Beclin 1-independent autophagy
in cell death induced by resveratrol in human breast cancer cells.
Cell Death Differ. 15:1318–1329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Di X, Shiu RP, Newsham IF and Gewirtz DA:
Apoptosis, autophagy, accelerated senescence and reactive oxygen in
the response of human breast tumor cells to adriamycin. Biochem
Pharmacol. 77:1139–1150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Box VG: The intercalation of DNA double
helices with doxorubicin and nogalamycin. J Mol Graph Model.
26:14–19. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wirawan E, Van de Walle L, Kersse K,
Cornelis S, Claerhout S, Vanoverberghe I, Roelandt R, De Rycke R,
Verspurten J, Declercq W, et al: Caspase-mediated cleavage of
Beclin-1 inactivates Beclin-1-induced autophagy and enhances
apoptosis by promoting the release of proapoptotic factors from
mitochondria. Cell Death Dis. 1:e182010. View Article : Google Scholar : PubMed/NCBI
|
